ATE504598T1 - Cspcna-isoform-modifikationen und anwendungen davon - Google Patents

Cspcna-isoform-modifikationen und anwendungen davon

Info

Publication number
ATE504598T1
ATE504598T1 AT06785569T AT06785569T ATE504598T1 AT E504598 T1 ATE504598 T1 AT E504598T1 AT 06785569 T AT06785569 T AT 06785569T AT 06785569 T AT06785569 T AT 06785569T AT E504598 T1 ATE504598 T1 AT E504598T1
Authority
AT
Austria
Prior art keywords
applications
cspcna isoform
modifications
cspcna
isoform modifications
Prior art date
Application number
AT06785569T
Other languages
English (en)
Inventor
Derek Hoelz
Robert Hickey
Linda Malkas
Original Assignee
Univ Indiana Res & Tech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Indiana Res & Tech Corp filed Critical Univ Indiana Res & Tech Corp
Application granted granted Critical
Publication of ATE504598T1 publication Critical patent/ATE504598T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Insulating Materials (AREA)
AT06785569T 2005-06-27 2006-06-26 Cspcna-isoform-modifikationen und anwendungen davon ATE504598T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69415905P 2005-06-27 2005-06-27
PCT/US2006/024774 WO2007002574A2 (en) 2005-06-27 2006-06-26 Cspcna isoform modifications and uses thereof

Publications (1)

Publication Number Publication Date
ATE504598T1 true ATE504598T1 (de) 2011-04-15

Family

ID=37116243

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06785569T ATE504598T1 (de) 2005-06-27 2006-06-26 Cspcna-isoform-modifikationen und anwendungen davon

Country Status (11)

Country Link
US (2) US7932023B2 (de)
EP (1) EP1899373B1 (de)
JP (1) JP5090344B2 (de)
CN (1) CN101258161A (de)
AT (1) ATE504598T1 (de)
AU (1) AU2006261856B2 (de)
BR (1) BRPI0611703A2 (de)
CA (1) CA2612695A1 (de)
DE (1) DE602006021178D1 (de)
EA (1) EA013109B1 (de)
WO (1) WO2007002574A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007098415A2 (en) * 2006-02-17 2007-08-30 Indiana University Research And Technology Corporation Peptide based inhibition of capcna protein-protein interactions in cancer
WO2010011890A2 (en) * 2008-07-24 2010-01-28 Indiana University Research And Technology Corporation Cancer peptide therapeutics
WO2011044372A1 (en) * 2009-10-09 2011-04-14 Indiana University Research And Technology Corporation Pcna methyltransferase
US8455200B2 (en) 2009-10-15 2013-06-04 Traxxsson, Llc Measurement of PKA for cancer detection
US20130345231A1 (en) * 2011-03-23 2013-12-26 Indiana University Research And Technology Corporation Anticancer therapeutic agents
US10420840B2 (en) * 2015-04-10 2019-09-24 Rll, Llc Anticancer therapeutic agents
TW202411650A (zh) * 2018-02-01 2024-03-16 美商再生元醫藥公司 治療性單株抗體之品質屬性的定量及模型化

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7294471B2 (en) * 2002-02-27 2007-11-13 Cskeys, Llc Method for purifying cancer-specific proliferating cell nuclear antigen

Also Published As

Publication number Publication date
WO2007002574A2 (en) 2007-01-04
EA200800144A1 (ru) 2008-06-30
AU2006261856A1 (en) 2007-01-04
JP2008547034A (ja) 2008-12-25
HK1112928A1 (en) 2008-09-19
US20090061432A1 (en) 2009-03-05
EP1899373A2 (de) 2008-03-19
US7932023B2 (en) 2011-04-26
EP1899373B1 (de) 2011-04-06
EA013109B1 (ru) 2010-02-26
WO2007002574A3 (en) 2007-05-03
BRPI0611703A2 (pt) 2011-12-20
CN101258161A (zh) 2008-09-03
US20110195510A1 (en) 2011-08-11
AU2006261856B2 (en) 2012-07-05
DE602006021178D1 (de) 2011-05-19
JP5090344B2 (ja) 2012-12-05
CA2612695A1 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
JO2778B1 (en) Certain Compounds, Compositions and Methods
BR112012014082A2 (pt) composições e métodos que compreendem variantes de protease
ATE475886T1 (de) Proteolipidmembran und lipidmembranen-biosensor
EP2513023A4 (de) Zusammensetzungen aus cis-1,1,1,4,4,4-hexafluor-2-buten und ihre verwendungen
ECSP10010722A (es) Compuestos orgánicos
EP1896073A4 (de) Anti-il-23-antikörper, zusammensetzungen, verfahren und verwendung
BR112012028467A2 (pt) composições e métodos que compreendem variantes de subtilisina
PA8713501A1 (es) INHIBIDORES DE 11-BETA HIDROXIESTEROIDE DEHIDROGENASA - 11ßHSD1
GT200800123A (es) Compuestos mimeticos de lisina modificados
MY173526A (en) Novel anti-?5?1 antibodies and uses thereof
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
EP1874351A4 (de) Anti-il-6-antikörper, zusammensetzungen, verfahren und anwendungen
ATE498134T1 (de) Nachweis von staphylococcus
CY1113916T1 (el) Παραγωγα ετεροαρυλο πυρρολιδινυλο και πιπεριδινυλο κετονης
PT2124573E (pt) Composição de ácaros
NO20071127L (no) Triazoloftalaziner
NO20073368L (no) Amid-promedikament av gemcitabin, sammensetninger og anvendelse derav
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
BRPI1015043A2 (pt) derivados de diazahomoadamantano e métodos de uso dos mesmos
EP2315747A4 (de) Verfahren und zusammensetzungen in verbindung mit synthetischen beta-1,6 glucosamin-oligosacchariden
MX373170B (es) Variantes de la familia il-1.
CR10280A (es) Anticuerpos de la efgl7 y metodos de uso
ATE549638T1 (de) 13c-mr-bildgebung oder spektroskopie von zelltod
HN2012001262A (es) Nuevos derivados de 8heterociclo-piperidina condensada)-( piperazinil)-1-alcanona o de (heterociclo-pirrolidina condensada)-(piperazinil)-1-alcanona y su utilizacion como inhibidores de p75
DK2327792T3 (da) Fremgangsmåder og sammensætninger til påvisning af autoimmunsygdomme

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties